Serial 98490808
Live / Applied — First extension granted (statement of use) (as of 28 Mar 2025)
What this means for you
Not registered yet, but its 09 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98490808
- Mark type
- Design / logo
- Filed
- 09 Apr 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Mar 2025 — SOU EXTENSION 1 FILED
- 28 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2024 — ASSIGNED TO EXAMINER
- 19 Sept 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 19 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Apr 2024 — NEW APPLICATION ENTERED